Economic and Socio-Political Aspects of Drug Provision as an Integral Part of Free Medical Care Guarantees: USSR, Russian Federation, Developed OECD Countries
( Pp. 180-193)
More about authors
Vladimir V. Grishin
Chief Researcher of the Center for Problems of Organization, Financing and Interterritorial Relations in Healthcare of the Institute of Regional Economics and Intergovernmental Relations, Doctor of Economics, Professor
Financial University under the Government of the Russian Federation
Moscow, Russian Federation Lidia A. Bykova Laboratory Researcher of the Center for Problems of Organization, Financing and Interterritorial Relations in Health Care of the Institute of Regional Economics and Intergovernmental Relations
Financial University under the Government of the Russian Federation
Moscow, Russian Federation
Financial University under the Government of the Russian Federation
Moscow, Russian Federation Lidia A. Bykova Laboratory Researcher of the Center for Problems of Organization, Financing and Interterritorial Relations in Health Care of the Institute of Regional Economics and Intergovernmental Relations
Financial University under the Government of the Russian Federation
Moscow, Russian Federation
Abstract:
The Soviet Union became the first country in the world with universal drug guarantees for the entire population, which in the period 1920-1935 received free medicines prescribed by a doctor not only for inpatient but also outpatient treatment. In 1935, this organization of drug provision was replaced by a complex system of benefits for some groups of the population, which is preserved today in the Russian Federation. The purpose of the study is to analyze the impact of the universality of drug guarantees on the economic efficiency of healthcare systems. Conclusions. Practical recommendations for the creation of a system of universal drug guarantees in the Russian Federation. The importance of the universality of guarantees of free drug provision is due, on the one hand, to the fact that the patient's intake of medicines prescribed by a doctor is an integral part of medical care. Thus, the inability of citizens to purchase (receive) medicines prescribed to them within the framework of free medical care guaranteed to them in state and municipal institutions at the expense of the relevant budget, insurance premiums and other health care receipts de facto violates the right to free medical care guaranteed by Article 41 of the Constitution of the Russian Federation.
How to Cite:
Grishin V. V., Bykova L. A. Economic and Socio-Political Aspects of Drug Provision as an Integral Part of Free Medical Care Guarantees: USSR, Russian Federation, Developed OECD Countries // ECONOMIC PROBLEMS AND LEGAL PRACTICE. 2024. Vol. 20. № 6. P. 180-193. (in Russ.) DOI: 10.33693/2541-8025-2024-20-6-180-193. EDN: SOJGCC
Reference list:
Sokol M.C., McGuigan K.A., Verbrugge R.R., Epstein R.S. (2005) Impact of medication adherence on hospitalization risk and healthcare cost. Medical Care 43: 521–530.
Jha A.K., Aubert R.E., Yao J., Teagarden J.R., Epstein R.S. Greater adherence to diabetes drugs is linked to less hospital use and could save nearly $5 billion annually. Health Aff (Millwood). 2012 Aug;31(8):1836-46. doi: 10.1377/hlthaff.2011.1198.
Sinnott S.J., Buckley C., O'Riordan D., Bradley C., Whelton H. The effect of copayments for prescriptions on adherence to prescription medicines in publicly insured populations; a systematic review and meta-analysis. PLoS One. 2013 May 28;8(5):e64914. doi: 10.1371/journal.pone.0064914. PMID: 23724105; PMCID: PMC3665806.
WHO. Adherence to Long-Term Therapies: Evidence for Action (World Health Organization, 2003).
Iuga, A. O. & McGuire, M. J. Adherence and health care costs. Risk Manag. Healthc. Policy 7, 35–44 (2014).
Lars, O. & Terrence, B. Adherence to medication. N. Engl. J. Med. 353, 487–497 (2005).
CDCBreastCancer. An update on cancer deaths in the United States. Centers for Disease Control and Prevention https://www.cdc.gov/cancer/dcpc/research/update-on-cancer-deaths/index.htm.
Kini, V. & Ho, P. M. Interventions to improve medication adherence: a review. JAMA 320, 2461 (2018).
CMS. NHE fact sheet. Centers for Medicare & Medicaid Services https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/NHE-Fact-Sheet (2021).
Congressional Budget Office. Offsetting effects of prescription drug use on Medicare’s spending for medical services. Congressional Budget Office https://www.cbo.gov/publication/43741 (2012).
Roebuck, M. C., Dougherty, J. S., Kaestner, R. & Miller, L. M. Increased use of prescription drugs reduces medical costs in medicaid populations. Health Aff. 34, 1586–1593 (2015).
Alma-Ata Declaration. Adopted by the WHO International Conference on primary health care (Alma-Ata, 1978) https://www.un.org/ru/documents/decl_conv/declarations/almaata78.shtml.
Gatsan, V. V. The experience of introducing preferential provision of antihypertensive drugs to the population in pilot regions / V. V. Gatsan, E. V. Kleychuk // Modern socio-economic trends in the development of the pharmaceutical industry : a collective monograph.—Ufa : Aeterna Limited Liability Company, 2018. —pp. 20–37. —EDN XMVWTJ.
Drug reimbursement: when it will work and what threatens pharmacies // New pharmacy. —2020. —No. 6. —pp. 60–65. —EDN XGSXWB.
Nagibin O.A., Manukhina E.V., Komarov I.A. Regulatory and legal regulation of preferential drug provision in the Russian Federation//The Russian Medical and Biological Bulletin named after Academician I.P. Pavlov. 2019. Vol. 27. No. 4. pp. 520–529.
Kalinovskaya E.N. Russians buy most of the drugs for the treatment of CVD from the recommendations of the Ministry of Health at their own expense. Medvestnik, 09/23/2024. https://medvestnik.ru/content/news/Bolshuu-chast-lekarstv-dlya-lecheniya-SSZ-iz-rekomendacii-Minzdrava-rossiyane-pokupaut-za-svoi-schet.html?utm_source=main&utm_medium=center-main-left.
Global Legal Insights. https://www.globallegalinsights.com/.
Germany: Health Systems in Transition (HiT) profile [electronic resource]. —Access mode https://eurohealthobservatory.who.int/monitors/health-systems-monitor/countries-hspm/hspm/germany-2020 (accessed 06.06.2023).
Profile of the Belgian healthcare system: WHO [Electronic resource]. —Mode of access: https://eurohealthobservatory.who.int/monitors/health-systems-monitor/countries-hspm/hspm/belgium-2020/financing/overview-of-the-statutory-financing-system/ (accessed 25.09.2023).
Center for European and International Relations in the field of social security: The Belgian health system [Electronic resource]. —Mode of access: https://www.cleiss.fr/docs/systemes-de-sante/belgique.html (accessed 25.09.2023).
European Observatory on Health Systems and Policies (2022), Belgium: Health System Summary. WHO Regional Office for Europe on behind the European Observatory on Health Systems and Policies, Copenhagen.
Bachner F., Bobek J., Habimana K., Ladurner J., Lepuschütz L., Ostermann H., Rainer L., Schmidt A.E., Zuba M., Quentin W., Winkelmann J. Austria: Health system review. Health Systems in Transition, 2018; 20(3): 1–256.
Profile of the Austrian healthcare system: WHO [Electronic resource]. —Mode of access: https://eurohealthobservatory.who.int/monitors/health-systems-monitor/countries-hspm/hspm/austria-2018 (accessed 25.09.2023).
Chevreul K., Berg Brigham K., Durand-Zaleski I., Hernández-Quevedo C. France: Health system review. Health Systems in Transition, 2015; 17 (3): 1-218.
Profile of the Italian healthcare system: WHO [Electronic resource]. —Mode of access: https://eurohealthobservatory.who.int/monitors/health-systems-monitor/countries-hspm/hspm/italy-2023/financing/overview-of-the-statutory-financing-system/.
de Belvis A.G., Meregaglia M., Morsella A., Adduci A., Perilli A., Cascini F., Solipaca A., Fattore G., Ricciardi W., Maresso A., Scarpetti G. Italy: Health system review. Health Systems in Transition, 2022; 24(4): pp.1–203.
Garattini, L., Badinella Martini, M. & Zanetti, M. The Italian NHS at regional level: same in theory, different in practice. Eur J Health Econ 23, 1–5 (2022). https://doi.org/10.1007/s10198-021-01322-z.
Profile of the Spanish health system: WHO [Electronic resource]. —Mode of access: https://eurohealthobservatory.who.int/monitors/health-systems-monitor/countries-hspm/hspm/spain-2018/financing/overview-of-the-statutory-financing-system/ (accessed 25.09.2023).
Bernal-Delgado E., García-Armesto S., Oliva J., Sánchez Martínez F.I., Repullo J.R., PeñaLongobardo L.M., Ridao-López M., Hernández-Quevedo C. Spain: Health system review. Health Systems in Transition, 2018;20(2):1-179.
Janlöv N., Blume S., Glenngård A.H., Hanspers K., Anell A., Merkur S. Sweden: Health system review. Health Systems in Transition, 2023; 25(3): 1–198.
The United Kingdom: Health system review. Health Systems in Transition 2022: WHO [electronic resource]. —Access mode https://eurohealthobservatory.who.int/publications/i/united-kingdom-health-system-review-2022 (accessed 24.06.2023).
The United Kingdom: Health System Summary 2022: WHO. —Access mode https://eurohealthobservatory.who.int/publications/i/united-kingdom-health-system-summary https://eurohealthobservatory.who.int/publications/i/united-kingdom-health-system-summary (accessed 24.06.2023).
Simões J., Augusto G.F., Fronteira I., Hernández-Quevedo C. Portugal: Health system review. Health Systems in Transition, 2017; 19(2):1-184.
Rice T., Rosenau P., Unruh L.Y., Barnes A.J., van Ginneken E. United States of America: Health system review. Health Systems in Transition, 2020; 22(4): pp.1-441.
O'nolan, Gerald & Lombard, John. (2019). Healthcare Financing in Ireland. ResearchGate [electronic resource]. —Access mode https://www.researchgate.net/publication/330926501_Healthcare_Financing_in_Ireland (accessed 24.06.2023).
The National Treatment Purchase Fund: Ireland. —Access mode https://www.ntpf.ie/home/home.htm (accessed 06/24/2023)
National Health Procurement Fund: Ireland [Electronic resource]. —Access mode https://www.ntpf.ie/home/home.htm (accessed 24.06.2023)
Australia: Health system review. Health Systems in Transition 2006: WHO [electronic resource]. —Access mode https://iris.who.int/handle/10665/107803 (accessed 24.06.2023).
How to get PBS medicines. https://www.servicesaustralia.gov.au/how-to-get-pbs-medicines?context=22016.
Sowada C., Sagan A., Kowalska-Bobko I., Badora-Musiał K., Bochenek T., Domagała A., Dubas-Jakóbczyk K., Kocot E., Mrożek-Gąsiorowska M., Sitko S., Szetela A., Szetela P., Tambor M., Więckowska B., Zabdyr-Jamróz M., van Ginneken E. Poland: Health system review. Health Systems in Transition, 2019; 21(1): 1–235.
Jha A.K., Aubert R.E., Yao J., Teagarden J.R., Epstein R.S. Greater adherence to diabetes drugs is linked to less hospital use and could save nearly $5 billion annually. Health Aff (Millwood). 2012 Aug;31(8):1836-46. doi: 10.1377/hlthaff.2011.1198.
Sinnott S.J., Buckley C., O'Riordan D., Bradley C., Whelton H. The effect of copayments for prescriptions on adherence to prescription medicines in publicly insured populations; a systematic review and meta-analysis. PLoS One. 2013 May 28;8(5):e64914. doi: 10.1371/journal.pone.0064914. PMID: 23724105; PMCID: PMC3665806.
WHO. Adherence to Long-Term Therapies: Evidence for Action (World Health Organization, 2003).
Iuga, A. O. & McGuire, M. J. Adherence and health care costs. Risk Manag. Healthc. Policy 7, 35–44 (2014).
Lars, O. & Terrence, B. Adherence to medication. N. Engl. J. Med. 353, 487–497 (2005).
CDCBreastCancer. An update on cancer deaths in the United States. Centers for Disease Control and Prevention https://www.cdc.gov/cancer/dcpc/research/update-on-cancer-deaths/index.htm.
Kini, V. & Ho, P. M. Interventions to improve medication adherence: a review. JAMA 320, 2461 (2018).
CMS. NHE fact sheet. Centers for Medicare & Medicaid Services https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/NHE-Fact-Sheet (2021).
Congressional Budget Office. Offsetting effects of prescription drug use on Medicare’s spending for medical services. Congressional Budget Office https://www.cbo.gov/publication/43741 (2012).
Roebuck, M. C., Dougherty, J. S., Kaestner, R. & Miller, L. M. Increased use of prescription drugs reduces medical costs in medicaid populations. Health Aff. 34, 1586–1593 (2015).
Alma-Ata Declaration. Adopted by the WHO International Conference on primary health care (Alma-Ata, 1978) https://www.un.org/ru/documents/decl_conv/declarations/almaata78.shtml.
Gatsan, V. V. The experience of introducing preferential provision of antihypertensive drugs to the population in pilot regions / V. V. Gatsan, E. V. Kleychuk // Modern socio-economic trends in the development of the pharmaceutical industry : a collective monograph.—Ufa : Aeterna Limited Liability Company, 2018. —pp. 20–37. —EDN XMVWTJ.
Drug reimbursement: when it will work and what threatens pharmacies // New pharmacy. —2020. —No. 6. —pp. 60–65. —EDN XGSXWB.
Nagibin O.A., Manukhina E.V., Komarov I.A. Regulatory and legal regulation of preferential drug provision in the Russian Federation//The Russian Medical and Biological Bulletin named after Academician I.P. Pavlov. 2019. Vol. 27. No. 4. pp. 520–529.
Kalinovskaya E.N. Russians buy most of the drugs for the treatment of CVD from the recommendations of the Ministry of Health at their own expense. Medvestnik, 09/23/2024. https://medvestnik.ru/content/news/Bolshuu-chast-lekarstv-dlya-lecheniya-SSZ-iz-rekomendacii-Minzdrava-rossiyane-pokupaut-za-svoi-schet.html?utm_source=main&utm_medium=center-main-left.
Global Legal Insights. https://www.globallegalinsights.com/.
Germany: Health Systems in Transition (HiT) profile [electronic resource]. —Access mode https://eurohealthobservatory.who.int/monitors/health-systems-monitor/countries-hspm/hspm/germany-2020 (accessed 06.06.2023).
Profile of the Belgian healthcare system: WHO [Electronic resource]. —Mode of access: https://eurohealthobservatory.who.int/monitors/health-systems-monitor/countries-hspm/hspm/belgium-2020/financing/overview-of-the-statutory-financing-system/ (accessed 25.09.2023).
Center for European and International Relations in the field of social security: The Belgian health system [Electronic resource]. —Mode of access: https://www.cleiss.fr/docs/systemes-de-sante/belgique.html (accessed 25.09.2023).
European Observatory on Health Systems and Policies (2022), Belgium: Health System Summary. WHO Regional Office for Europe on behind the European Observatory on Health Systems and Policies, Copenhagen.
Bachner F., Bobek J., Habimana K., Ladurner J., Lepuschütz L., Ostermann H., Rainer L., Schmidt A.E., Zuba M., Quentin W., Winkelmann J. Austria: Health system review. Health Systems in Transition, 2018; 20(3): 1–256.
Profile of the Austrian healthcare system: WHO [Electronic resource]. —Mode of access: https://eurohealthobservatory.who.int/monitors/health-systems-monitor/countries-hspm/hspm/austria-2018 (accessed 25.09.2023).
Chevreul K., Berg Brigham K., Durand-Zaleski I., Hernández-Quevedo C. France: Health system review. Health Systems in Transition, 2015; 17 (3): 1-218.
Profile of the Italian healthcare system: WHO [Electronic resource]. —Mode of access: https://eurohealthobservatory.who.int/monitors/health-systems-monitor/countries-hspm/hspm/italy-2023/financing/overview-of-the-statutory-financing-system/.
de Belvis A.G., Meregaglia M., Morsella A., Adduci A., Perilli A., Cascini F., Solipaca A., Fattore G., Ricciardi W., Maresso A., Scarpetti G. Italy: Health system review. Health Systems in Transition, 2022; 24(4): pp.1–203.
Garattini, L., Badinella Martini, M. & Zanetti, M. The Italian NHS at regional level: same in theory, different in practice. Eur J Health Econ 23, 1–5 (2022). https://doi.org/10.1007/s10198-021-01322-z.
Profile of the Spanish health system: WHO [Electronic resource]. —Mode of access: https://eurohealthobservatory.who.int/monitors/health-systems-monitor/countries-hspm/hspm/spain-2018/financing/overview-of-the-statutory-financing-system/ (accessed 25.09.2023).
Bernal-Delgado E., García-Armesto S., Oliva J., Sánchez Martínez F.I., Repullo J.R., PeñaLongobardo L.M., Ridao-López M., Hernández-Quevedo C. Spain: Health system review. Health Systems in Transition, 2018;20(2):1-179.
Janlöv N., Blume S., Glenngård A.H., Hanspers K., Anell A., Merkur S. Sweden: Health system review. Health Systems in Transition, 2023; 25(3): 1–198.
The United Kingdom: Health system review. Health Systems in Transition 2022: WHO [electronic resource]. —Access mode https://eurohealthobservatory.who.int/publications/i/united-kingdom-health-system-review-2022 (accessed 24.06.2023).
The United Kingdom: Health System Summary 2022: WHO. —Access mode https://eurohealthobservatory.who.int/publications/i/united-kingdom-health-system-summary https://eurohealthobservatory.who.int/publications/i/united-kingdom-health-system-summary (accessed 24.06.2023).
Simões J., Augusto G.F., Fronteira I., Hernández-Quevedo C. Portugal: Health system review. Health Systems in Transition, 2017; 19(2):1-184.
Rice T., Rosenau P., Unruh L.Y., Barnes A.J., van Ginneken E. United States of America: Health system review. Health Systems in Transition, 2020; 22(4): pp.1-441.
O'nolan, Gerald & Lombard, John. (2019). Healthcare Financing in Ireland. ResearchGate [electronic resource]. —Access mode https://www.researchgate.net/publication/330926501_Healthcare_Financing_in_Ireland (accessed 24.06.2023).
The National Treatment Purchase Fund: Ireland. —Access mode https://www.ntpf.ie/home/home.htm (accessed 06/24/2023)
National Health Procurement Fund: Ireland [Electronic resource]. —Access mode https://www.ntpf.ie/home/home.htm (accessed 24.06.2023)
Australia: Health system review. Health Systems in Transition 2006: WHO [electronic resource]. —Access mode https://iris.who.int/handle/10665/107803 (accessed 24.06.2023).
How to get PBS medicines. https://www.servicesaustralia.gov.au/how-to-get-pbs-medicines?context=22016.
Sowada C., Sagan A., Kowalska-Bobko I., Badora-Musiał K., Bochenek T., Domagała A., Dubas-Jakóbczyk K., Kocot E., Mrożek-Gąsiorowska M., Sitko S., Szetela A., Szetela P., Tambor M., Więckowska B., Zabdyr-Jamróz M., van Ginneken E. Poland: Health system review. Health Systems in Transition, 2019; 21(1): 1–235.
Keywords:
drug guarantees, adherence to treatment, healthcare, USSR, Russian Federation, OECD countries, economic efficiency..
Related Articles
1. THEORY AND HISTORY LAW Pages: 13-16 Issue №20339
Constitutional Spiritual and Moral Values of Russia: Reflections on the Text of the Constitution of the Russian Federation
Russian Empire
USSR
Russian Federation
spiritual and moral values
Constitution of the Russian Federation
Show more
6. THEORY AND HISTORY OF LAW AND STATE; HISTORY OF LAW AND STATE TEACHINGS 12.00.01 Pages: 115-120 Issue №19821
Modern Migration Policy of Russian Federation
migration policy
modern stage
Russian Federation
migration processes
migration registration
Show more
International Relations Pages: 152-161 DOI: 10.33693/2223-0092-2023-13-2-152-161 Issue №22898
О законе РФ «О соглашениях о разделе продукции» глазами китайских ученых
Russian Federation
Law on Production Sharing Agreements
foreign investment
Sino-Russian energy cooperation
Show more
7. Constitutional law; Constitutional judicial process; Municipal law Pages: 92-95 Issue №7973
THE FEDERAL LEGISLATION PROVIDING PUBLIC ADMINISTRATION WITH ELECTORAL PROCESS IN THE RUSSIAN FEDERATION
Federal legislation
Russian Federation
power
freedom
elections
Show more
Philosophical Anthropology, Philosophy of Culture Pages: 160-167 DOI: 10.33693/2223-0092-2023-13-6-160-167 Issue №46090
The Influence of Ethnic Identity Attributes on the Formation of National Security: The Russian Aspect
ethnicity
nationality
ethnic identity
self-identification
national security
Show more
9. NATIONAL HISTORY Pages: 89-93 Issue №9089
Part 3. THE HISTORICAL EXPERIENCE OF POLICE ACTIVITIES IN COMBATING ILLICIT TRAFFICKING IN FIREARMS IN RUSSIA AFTER THE GREAT PATRIOTIC WAR
illegal trafficking in firearms
the acquisition of firearms
police
The Council Of People's Commissars
Decree
Show more
LIVING HISTORY Pages: 159-165 DOI: 10.33693/2658-4654-2024-6-4-159-165 Issue №164805
Researcher of the «Solar Wind» or a Little about Oleg Leonidovich Weisberg: On His 90th Anniversary
space research
astrophysics
devices
O.L. Weisberg
USSR
Show more
3. Constitutional law; Constitutional judicial process; Municipal law Pages: 72-74 Issue №6998
CONSTITUTIONAL AND LEGAL FOUNDATIONS OF FREEDOM OF THE MEDIA IN THE RUSSIAN FEDERATION
Russian Federation
information
freedom of speech
right
Show more
7. Theory and history of law and state; History of law and State teachings Pages: 76-81 Issue №10327
INTERNATIONAL EXPERIENCE OF THE SOVIET UNION
international personality
the subjects of the Federation
international activities of the Soviet republics
UN
USSR
Show more
International Relations Pages: 111-120 DOI: 10.33693/2223-0092-2023-13-3-111-120 Issue №23055
Modern Tools of Direct Democracy in the Public Life
direct democracy
referendum
initiative
citizen society
social sphere
Show more
